Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Scutellarin
Cat. No.:
0225LY-0970
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Scutellarin is an active flavone from Scutellaria baicalensis that suppresses HCC cell signaling via the STAT3/Girdin/Akt pathway and inhibits MAPK/NF-κB signaling in osteoclasts.
Synonym:
Breviscapin; Breviscapinun; Breviscapine; Scutellarein-7-glucuronide; 27740-01-8; Scutellarin B; Scutellarein-7-glucuronide; Breviscapine; Scutellarein-7beta-D-glucuronide; Scutellarein 7-beta-D-glucuronide; Scutellarein-7beta-D-glucuronoside; Scutellarein-7-O-beta-D-glucuronide; dengzhanhua; beta-D-Glucopyranosiduronic acid, 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-7-yl; new-breviscapine; Scutellarein 7-O-beta-D-glucuronide; (2S,3S,4S,5R,6S)-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid; (2S,3S,4S,5R,6S)-6-((5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
CAS No.:
27740-01-8
Compound CID:
185617
Formula:
C21H18O12
Formula Weight:
462.36
Specification
Relative Density:
1.81 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Scutellarin can be used in cardiovascular research to investigate its neuroprotective and vasodilator properties.
Library Information
Target:
STAT; Akt
Receptor:
STAT; Akt
Pathways:
Stem cell regulation; Proteases/Proteasome; Cytoskeletal signaling; Microbiology/Virology; JAK/STAT signaling; PI3K/Akt/mTOR signaling
Plate Number:
AOCL-13
Plate Location:
d11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
240 mg/mL; 519.08 mM





